Indraprastha Medical Corporation Reports Strong Financial Performance in Q1 FY25

Indraprastha Medical Corporation, a smallcap healthcare services company, has recently declared its financial results for the quarter ended June 2024. The company has shown a very positive performance in this quarter, with a significant improvement in its financial score from 13 to 20 in the last 3 months.

One of the key highlights of the quarter is the growth in Profit Before Tax (PBT) less Other Income, which has increased by 48.54% year on year. This trend is expected to continue in the near term. Similarly, the Profit After Tax (PAT) has also shown a growth of 46.8% year on year, indicating a positive trend in the company’s profitability.

Indraprastha Medical Corporation has also shown a strong performance in terms of inventory management, with the Inventory Turnover Ratio being the highest at 165.30 times in the last five half yearly periods. This shows that the company has been able to sell its inventory at a faster rate, resulting in better cash flow.

The company’s net sales for the quarter have also been the highest in the last five quarters, at Rs 347.86 crore. This indicates a positive trend in the company’s sales performance. The Operating Profit (PBDIT) has also been the highest at Rs 67.12 crore in the last five quarters, showing a positive trend in the company’s operational efficiency.

Indraprastha Medical Corporation has also been able to improve its operating profit margin, which is the highest at 19.30% in the last five quarters. This indicates that the company has become more efficient in managing its costs and expenses.

The company’s profitability has also been reflected in its Earnings per Share (EPS), which is the highest at Rs 4.88 in the last five quarters. This shows that the company has been able to create higher earnings for its shareholders.

On the downside, the company’s Non Operating Income has shown an increase in the last five quarters, which may not be sustainable in the long run. However, this does not overshadow the overall positive performance of Indraprastha Medical Corporation in the quarter ended June 2024.

Based on these financial results, MarketsMOJO has given a ‘Buy’ call for Indraprastha Medical Corporation’s stock. With a strong financial performance and positive trends in key indicators, the company is poised for growth in the near future. Investors can consider adding Indraprastha Medical Corporation to their portfolio for potential returns.